Delivery Order SPE2DB20D1100-SPE2DB25FD4K8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Azelastine 0.1% (137 mcg) spray in a 30 ml format, with a ceiling value of $2,352.57. This non-competitive, firm fixed-price delivery order, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, represents a pharmaceutical supply transaction under DLA's medical procurement operations. The order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Azelastine 0.1% (137 mcg) spray in 30 mL containers, with a ceiling value of $3,225.60. This non-competitive delivery order represents a firm fixed-price procurement and is scheduled for completion by August 21, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a $1,002.16 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Azelastine 0.1% (137 mcg) spray in a 30ml formulation. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 26, 2025. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azelastine HCL 0.05% ophthalmic drops (6ml units) with a ceiling value of $1,809.36. This non-competitive, firm fixed-price delivery order was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025. The product will be delivered from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,541.53 delivery order to AmerisourceBergen Drug Corp for Azelastine 0.1% (137 MCG) spray in 30ML quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a child order under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $119.60 to Amerisourcebergen Drug Corporation for 4561435749 AZELASTINE HCL 0.05% drops, 6mL. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 10, 2023 to support Defense Logistics Agency requirements. The parent company, Amerisourcebergen Corporation, will perform through its Amerisourcebergen division. No...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Azelastine 0.1% nasal spray (137 micrograms, 30 milliliter formulation). This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a ceiling value of $1,000.89 and an ultimate completion date of August 22, 2025. The award represents a single-day turnaround delivery requirement, reflecting the urgent...
- This is a $3,376.01 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the supply of Azelastine 0.1% (137 MCG) spray, a prescription medication, with a completion date of March 6, 2024. This delivery order is placed under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $348 delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. Under this firm fixed price contract, Amerisourcebergen will supply approximately 137 milligrams of 0.1% azelastine hydrochloride nasal spray packaged in 30 milliliter bottles to a Defense Logistics Agency facility located in Conshohocken, Pennsylvania. The period of performance is August 3, 2023 through August 4, 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $925.84 to Amerisourcebergen Drug Corporation for the supply of 4562149514, azelastine hydrochloride 0.1% nasal spray. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is one day, from September 13, 2023 through September 14, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this order for...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD4K8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Azelastine HCL 0.05% drops in 6 mL quantities, with a ceiling value of $6,662.54. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of July 16, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor within the federal medical procurement system, particularly supporting military and veteran healthcare initiatives. The SPE2DX prime contract serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, vaccines, and other medical commodities across multiple therapeutic domains. This delivery order for Azelastine HCL, an antihistamine nasal spray commonly used for allergy management, exemplifies the company's ongoing role in fulfilling medical supply requirements for the Defense Health Agency and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.7k | 7/15/25 |